ARCHIVES

NCI Phase II Trial Tests Vaccine Plus Hormone Therapy For Recurrent Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

SWOG Seeks NSCLC Patients For Study Of Gender Differences In Lung Cancer

October 28, 2005

FDA Approves Xeloda For Breast Cancer Treatment.

September 28, 2001

DCBD Board Okays New Program Projects For Diagnosis Research

June 7, 1985

Push to Get Exceptions, Adjustments For Clinical Research In DRG Regulations Gaining Momentum

July 22, 1983

Herberman: Progress Made To Stabilize NSABP

September 9, 1994

Clinical Trials Approved By NCI Last Month Are Listed

August 29, 2003